Papers

3

Total Citations

37

H-Index

2

About

Gerald David is a pioneering colorectal surgeon whose research centers on advancing robotic surgery for complex gastrointestinal cancers and emergency general surgery. His most impactful work focuses on robotic complete mesocolic excision (CME) for right colon cancers, demonstrating that this minimally invasive approach is both safe and feasible—a critical finding given the technical challenges that have historically limited adoption. His 2021 study on robotic CME, with 26 citations, provides essential short- and midterm outcome data from a single-centre experience, helping to build the evidence base for robotic colorectal oncology. David has also addressed specific surgical challenges, notably in obese patients, where he pioneered the novel use of intra-operative robotic ultrasound to facilitate superior mesenteric vein dissection—a technique that earned 10 citations for its practical innovation. More recently, he has explored the frontier of robotic emergency general surgery, publishing a case-matched comparison that evaluates safety and outcomes during the adoption phase in a high-volume tertiary centre. Through these contributions, David is helping to expand the boundaries of robotic surgery from elective to emergency settings, improving surgical precision and patient outcomes in colorectal cancer care.

Research Focus

Key Achievements

2
H-Index
3
Papers
37
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Complete Mesocolic Excision (CME) is a safe and feasible option for right colonic cancers: short and midterm results from a single-centre experience
26 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago